These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
794 related articles for article (PubMed ID: 29298665)
1. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma. Ren FH; Yang H; He RQ; Lu JN; Lin XG; Liang HW; Dang YW; Feng ZB; Chen G; Luo DZ BMC Cancer; 2018 Jan; 18(1):12. PubMed ID: 29298665 [TBL] [Abstract][Full Text] [Related]
2. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144 [TBL] [Abstract][Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR‑136‑5p in hepatocellular carcinoma and its clinicopathological significance. Ding H; Ye ZH; Wen DY; Huang XL; Zeng CM; Mo J; Jiang YQ; Li JJ; Cai XY; Yang H; Chen G Mol Med Rep; 2017 Oct; 16(4):5393-5405. PubMed ID: 28849100 [TBL] [Abstract][Full Text] [Related]
5. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics. Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133 [TBL] [Abstract][Full Text] [Related]
6. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop. Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294 [TBL] [Abstract][Full Text] [Related]
7. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618 [TBL] [Abstract][Full Text] [Related]
8. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis. Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma. Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172 [TBL] [Abstract][Full Text] [Related]
10. Deciphering the Molecular Complexity of Hepatocellular Carcinoma: Unveiling Novel Biomarkers and Therapeutic Targets Through Advanced Bioinformatics Analysis. Moghimi A; Bani Hosseinian N; Mahdipour M; Ahmadpour E; Miranda-Bedate A; Ghorbian S Cancer Rep (Hoboken); 2024 Aug; 7(8):e2152. PubMed ID: 39118438 [TBL] [Abstract][Full Text] [Related]
11. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification. He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: Findings based on RT-qPCR and in silico analysis. Wu HY; Cai KT; Ma J; Chen G; Dang YW; Lu HP; Pan SL Pathol Res Pract; 2019 Jul; 215(7):152424. PubMed ID: 31103408 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data. Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053 [TBL] [Abstract][Full Text] [Related]
14. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma. Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964 [TBL] [Abstract][Full Text] [Related]
15. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
16. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis. Li L; Lei Q; Zhang S; Kong L; Qin B Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study. Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686 [TBL] [Abstract][Full Text] [Related]
18. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236 [TBL] [Abstract][Full Text] [Related]
19. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC. Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391 [TBL] [Abstract][Full Text] [Related]
20. Microarray-based measurement of microRNA-449c-5p levels in hepatocellular carcinoma and bioinformatic analysis of potential signaling pathways. Jiang L; Wu CL; Wu JZ; Yang X; Wang HL; Li GJ Pathol Res Pract; 2019 Jan; 215(1):68-81. PubMed ID: 30389318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]